Intended Use Package Storage Specimen Type Shelf life Time to result Detection of SARS-CoV2 antigen 20 Tests / kit 1 - 40 Nasopharynx / Nasopharyngeal 24 months from manufacture date 5 - 8 minutes
colloidal gold method
Softec Pregnancy Rapid Test kits
Product Details: Number of Reactions(Preps)/Kit :30T Brand : SD Biosensor ICMR Approved : Yes Result Time (Rapid Kits) : 10 min CAT No : RK019-30 STANDARD Q HIV 1/2 Ab 3-Line performs qualitative analysis by detecting antibodies specific to HIV-1 (including Group O) and HIV-2 in serum, plasma and whole blood using immunochromatography. With a simple test method, HIV infection status can be discriminated, and with its high sensitivity and specificity, the screening test result can be obtained within 10 minutes. Easy to use, Easy to read and interpret Discrimination between HIV-1 and HIV-2 antibodies Room temperature storage Performance Sensitivity : 100% (74/74)/ Specificity : 100% (232/232)
A rapid in vitro qualitative immunoassay for detection of antibodies to the Human Immunodeficiency Virus Type 1 (HIV-1) and Type 2 (HIV-2) Clear, dependable results in 15 minutes Requires minimal training and no equipment So easy it can be used at the lowest levels of health care service Can use whole blood or serum/plasma Collection can be by fingerstick or venipuncture No refrigeration required Storage conditions 2-30�°C
COVID-19 Ag Rapid Test Device is an in vitro diagnostic rapidtest for the qualitative detection of antigen (Ag) in humannasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. COVID-19 Ag RapidTest Device is for professional use only and is intended to be used asan aid in the diagnosis of
COVID-19 serology test.Cellex qSARS-CoV-2 IgG/IgM Rapid Test.qSARS-CoV-2 IgG/IgM Rapid Test Cassette.FDA Grants Emergency Authorization for First Rapid Antibody Test for COVID-19
CAT No : RCHM-02071. The CareStar COVID-19 Antigen test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within first five days of symptom onset, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests.
A serology test or Antibody Rapid Test which doesn't test for the virus itself. Instead, it look for body's immune response to the virus. This test is getting popular is not only because its convenience but also because it can identify whether youâ??ve ever been exposed to SARS-CoV-2 - which would deepen our understanding of who is getting sick, particularly people who showed few or no symptoms. It could also allow people whose bodies seem to have some degree of immunity to the illness to return to work more quickly. Please email us and get detailed factsheet, certification etc.
GOLD STANDARD for diagnosis novel coronavirus. This kit is based on one-step RT-PCR technique. Used for the in vitro qualitative detection of novel coronavirus (2019-nCoV) ORF1ab and N gene in the throat swabs, sputum specimens of suspected pneumonia patients infected by novel coronavirus, suspected clustering cases and others needing diagnosis or differential diagnosis for novel coronavirus. No cross-reaction, sensitivity is 500 copies/ml. CFDA/CE. Applicable Instruments include ABI 7500 & LightCycler480.
Availability: 6M units as per today 21.11.21, goods ready to go, with an option to extend Price: $4.20 per unit Comms open: $0.10 Delivery: 10-14 days from deposit 30% (CIF USA, Air freight) Payment terms: 30% deposit upon order confirmation, 70% upon receipt of Documentation â?? Documents are: Packing list, SGS, AWB, Letter of Export and Invoice Note: Must be as per FDA cleared under EUA, buyer responsible for custom clearance (7%). Seller can give a guarantee, PB. Procedure: PO to our partner, who is direct to the allocation holder.
2019-nCoV Neutralizing Antibody Test Kit Fluorescence Immunochromatography (Serum/plasma) Rapid Test: Just for 15 Minutes Accurate Result: Fluorescence immunoassay, high sensitivity Convenient operation with smart POCT analyzers Rate COVID-19 Vaccine immediately Application By testing neutralizing antibody titer after COVID-19 Vaccination, it will be able to figure out the vaccine efficiency Product Information Product Name: 2019-nCoV Neutralizing Antibody Determination Kit Methodology:Fluorescence immunoassay Size:25 Tests/box Storage and Validity:Stored at 2-30 within 18 months Specimen:-Clinical fresh human serum, recommended EDTA anticoagulant plasma Easy Operation: 1 Take 100 sample to buffer and mix 5-10s 2 Add 80 mixed sample to strip 3 Incubation time: 15 mins 4 Put strip into analyzer to test
#b2b #Manufacturer #Exporter #COVID-19 #Stock #Antigen rapid test kit #anti-epidemic Provide high-quality products at competitive prices Product: SARS-CoV-2 Antigen Rapid Test Kit Standard: CE, FDA certification Packing quantity: 25tests/box FOB: US$1.60/test
*High reliability and accuracy *Rapid test *Easy and safe to use *Made in korea
*Rapid test kit. *Easy and safe to use. *High reliability and accuracy *Made in korea
Certification - Test report-Certified Daily manufacturer output - 200,000 Price - $15.00 per test
COVID 19 RApid Test Kit
It's special designed to detect the Beta-lactam,Tetracyclines in raw, commingled cow milk at or below established tolerance and/or safe levels. The kit is only for screening test, positive result should be further confirmed with other method.
It's special designed to detect the Beta-lactam,Tetracyclines, Sulfonamides, Chloramphenicol in raw, commingled cow milk at or below established tolerance and/or safe levels. The kit is only for screening test, positive result should be further confirmed with other method.
Information Detail Test time Within 15 mins Specimen Whole blood/Serum/plasma Storage temperature 2-30/36-86 The BIOGENIX COVID-19 Rapid Test Kit is a qualitative lateral flow immunochromatographic assay for the detection of IgM and IgG antibodies to SARS-CoVID-19 in human whole blood, serum or plasma samples. It is intended for use as a tool to assist in the diagnosis of SARS-CoVID-19 infections. It is also intended as a tool for carrying out serological epidemiological investigations.
